Physician profile
Cinna Wohlmuth
NPI 1124025275
$611.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.60 · 2021: $65.41 · 2022: $72.38 · 2023: $385 · 2024: $14.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $149.71 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $67.71 | 2023 | Myfembree |
| Myovant Sciences INC. | $63.35 | 2021-2022 | |
| Myriad Women'S Health, INC. | $58.50 | 2023 | Myrisk |
| Baxter Healthcare | $49.05 | 2023 | Tisseel |
| Coopersurgical, INC. | $43.54 | 2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $31.08 | 2019 | |
| Ferring Pharmaceuticals INC. | $22.97 | 2019 | |
| Ethicon US, LLC | $20.89 | 2021 | |
| Amag Pharmaceuticals, INC. | $20.55 | 2019 | |
| Davol INC. | $19.21 | 2023 | Phasix Mesh |
| Hologic Sales and Service, LLC | $17.95 | 2023 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Biogen, INC. | $16.58 | 2021 | |
| Becton, Dickinson and Company | $15.80 | 2023 | Bd Onclarity |
| Exeltis, USA INC. | $14.52 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cinna Wohlmuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.